Corcept Therapeutics
CORT | NASDAQ
$81.19
+$0.07 (+0.09%)
Nov 2, 2026, 2:11 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 830.81M | 769.1M | 761.41M | 741.17M | 716.08M | 685.45M | 675.04M | 628.56M | 569.61M | 523.53M | 482.38M | 450.03M | 428.15M | 413.82M | 401.86M | 397.62M | 392.03M | 380.23M | 365.98M | 352.89M | 343.09M | 340.06M |
Cost of Revenue | 14.09M | 13.46M | 12.98M | 13.39M | 11.66M | 10.75M | 10.88M | 9.8M | 8.58M | 7.63M | 6.48M | 6.09M | 5.78M | 5.52M | 5.39M | 5.26M | 5.2M | 5.26M | 5.28M | 5.18M | 5.12M | 4.97M |
Gross Profit | 816.73M | 755.64M | 748.43M | 727.78M | 704.42M | 674.7M | 664.16M | 618.75M | 561.03M | 515.9M | 475.89M | 443.94M | 422.37M | 408.3M | 396.47M | 392.37M | 386.83M | 374.97M | 360.7M | 347.71M | 337.97M | 335.09M |
Operating Income | 6.41M | -8.22M | 44.8M | 65.57M | 101.95M | 110.87M | 136.95M | 143.36M | 127.94M | 121.93M | 107.28M | 98.11M | 98.87M | 100.72M | 112.63M | 126.8M | 131.1M | 131.61M | 124.48M | 118.32M | 106.81M | 110.13M |
Interest Income | 15.33M | 20.35M | 21.67M | 22.94M | 24.26M | 25.25M | 24.54M | 22.98M | 21.85M | 19.19M | 17.28M | 13.91M | 9.78M | 7.06M | 3.56M | 1.85M | 854K | 334K | 529K | 754K | 1.3M | 2.2M |
Pretax Income | 26.37M | 12.13M | 66.46M | 88.51M | 126.21M | 136.12M | 161.49M | 166.34M | 149.78M | 141.12M | 124.56M | 112.03M | 108.64M | 107.78M | 116.19M | 128.65M | 131.95M | 131.94M | 125.01M | 119.08M | 108.11M | 112.33M |
Net Income | 54.9M | 47.9M | 99.65M | 105.75M | 132.78M | 133.11M | 140.33M | 141.3M | 125.98M | 118.02M | 106.14M | 91.39M | 94.62M | 94.5M | 101.42M | 116.87M | 112.73M | 111.84M | 112.51M | 106.45M | 97.61M | 99.41M |
Selling & General & Admin | 556.47M | 503.42M | 448.73M | 401.86M | 351.63M | 314.71M | 280.32M | 244.1M | 215.62M | 191.96M | 184.26M | 179.43M | 169.33M | 163.86M | 152.85M | 142.81M | 138.18M | 130.4M | 122.36M | 115.77M | 111.76M | 107.3M |
Research & Development | 253.86M | 260.44M | 254.91M | 260.35M | 250.84M | 249.12M | 246.89M | 231.29M | 217.47M | 202.01M | 184.35M | 166.4M | 154.17M | 143.72M | 130.99M | 122.76M | 117.56M | 112.96M | 113.86M | 113.62M | 119.4M | 117.66M |
Other Expenses | 1 | 1 | 1 | n/a | n/a | 500K | 500K | 500K | 500K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 810.32M | 763.86M | 703.63M | 662.21M | 602.47M | 563.83M | 527.21M | 475.39M | 433.09M | 393.97M | 368.61M | 345.83M | 323.51M | 307.59M | 283.84M | 265.57M | 255.74M | 243.36M | 236.22M | 229.39M | 231.16M | 224.96M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 824.41M | 777.32M | 716.61M | 675.6M | 614.13M | 574.58M | 538.09M | 485.2M | 441.67M | 401.6M | 375.09M | 351.91M | 329.28M | 313.11M | 289.22M | 270.83M | 260.93M | 248.62M | 241.5M | 234.57M | 236.28M | 229.94M |
Income Tax Expense | -35.26M | -35.77M | -33.19M | -17.6M | -7.44M | 2.12M | 20.28M | 24.52M | 23.8M | 23.09M | 18.42M | 20.64M | 14.03M | 13.28M | 14.77M | 11.78M | 19.22M | 20.1M | 12.49M | 12.62M | 10.51M | 12.92M |
Shares Outstanding (Basic) | 105.38M | 104.44M | 103.7M | 103.55M | 104.11M | 104.11M | 103.64M | 103.37M | 103.12M | 102.79M | 102.46M | 102.01M | 101.96M | 107.89M | 107.7M | 115.17M | 114.16M | 113.99M | 113.74M | 115.79M | 116.29M | 116.82M |
Shares Outstanding (Diluted) | 118.39M | 104.44M | 119.86M | 119.44M | 120.49M | 119.82M | 118.46M | 113.72M | 111.24M | 109.92M | 110.89M | 111.1M | 109.59M | 115.43M | 116.33M | 116.62M | 115.4M | 115.04M | 122.43M | 125.14M | 126.68M | 129.67M |
EPS (Basic) | 0.52 | 0.45 | 0.94 | 1 | 1.26 | 1.27 | 1.35 | 1.36 | 1.22 | 1.15 | 1.03 | 0.88 | 0.87 | 0.84 | 0.89 | 1.02 | 0.98 | 0.97 | 0.97 | 0.91 | 0.84 | 0.86 |
EPS (Diluted) | 0.42 | 0.35 | 0.82 | 0.88 | 1.13 | 1.16 | 1.24 | 1.26 | 1.13 | 1.06 | 0.95 | 0.81 | 0.83 | 0.82 | 0.88 | 1 | 0.94 | 0.91 | 0.89 | 0.83 | 0.76 | 0.78 |
EBITDA | 28.79M | 14.16M | 68.35M | 90.38M | 128.1M | 137.8M | 162.83M | 167.79M | 151.02M | 142.4M | 126.02M | 113.66M | 110.74M | 110.23M | 119.16M | 131.67M | 134.99M | 135.07M | 127.8M | 121.34M | 109.55M | 112.51M |
EBIT | 26.37M | 12.13M | 66.46M | 88.51M | 126.21M | 136.12M | 161.49M | 166.34M | 149.78M | 141.12M | 124.56M | 112.03M | 108.64M | 107.78M | 116.19M | 128.65M | 131.95M | 131.94M | 124.73M | 118.51M | 106.92M | 110.13M |
Depreciation & Amortization | 2.42M | 2.03M | 1.89M | 1.87M | 1.89M | 1.68M | 1.34M | 1.45M | 1.24M | 1.29M | 1.46M | 1.63M | 2.1M | 2.46M | 2.97M | 3.02M | 3.04M | 3.13M | 3.07M | 2.83M | 2.63M | 2.38M |
Add to Watchlist
Select watchlists to add or remove CORT